Growth Metrics

Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026)

Trevi Therapeutics' quarterly Prepaid Assets came in at $2.2 million in Q1 2026, up 44.84% year-on-year from $1.5 million in Q1 2025, and up 3.89% quarter-over-quarter from $2.1 million in Q4 2025.

Trevi Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $2.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 44.84% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 44.84% YoY), and the FY2025 full-year result was $2.1 million, up 127.16% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $2.2 million, up from $2.1 million in the prior quarter.
  • The five-year high for Prepaid Assets was $4.0 million in Q3 2023, with the low at $382000.0 in Q2 2022.
  • Average Prepaid Assets over 5 years is $1.6 million, with a median of $1.3 million recorded in 2023.
  • Year-over-year, Prepaid Assets plunged 81.41% in 2022 and soared 859.38% in 2023.
  • Tracing TRVI's Prepaid Assets over 5 years: stood at $1.3 million in 2022, then decreased by 27.15% to $955000.0 in 2023, then retreated by 1.68% to $939000.0 in 2024, then jumped by 127.16% to $2.1 million in 2025, then increased by 3.89% to $2.2 million in 2026.
  • The last three Prepaid Assets figures came in at $2.2 million (Q1 2026), $2.1 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Trevi Therapeutics 2.02 Bn 1.85 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.22 Mn
Dec 31, 2025 2.13 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 1.77 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 939,000.00
Sep 30, 2024 1.18 Mn
Jun 30, 2024 830,000.00
Mar 31, 2024 3.23 Mn
Dec 31, 2023 955,000.00
Sep 30, 2023 4.04 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 1.33 Mn
Dec 31, 2022 1.31 Mn
Sep 30, 2022 421,000.00
Jun 30, 2022 382,000.00
Mar 31, 2022 477,000.00
Dec 31, 2021 241,000.00
Sep 30, 2021 1.01 Mn
Jun 30, 2021 2.06 Mn
Mar 31, 2021 589,000.00
Dec 31, 2020 1.00 Mn
Sep 30, 2020 1.86 Mn
Jun 30, 2020 149,000.00
Mar 31, 2020 134,000.00
Dec 31, 2019 77,000.00
Sep 30, 2019 66,000.00
Jun 30, 2019 27,000.00
Mar 31, 2019 1.67 Mn
Dec 31, 2018 1.44 Mn